1423120-66-4 Usage
Uses
Used in Organic Synthesis:
6-Chloroindole-5-carbonitrile is used as a key building block in organic synthesis for the production of various indole-based compounds. Its unique structural features and reactivity make it a valuable component in creating a wide range of chemical products.
Used in Pharmaceutical Research:
In pharmaceutical research, 6-Chloroindole-5-carbonitrile is utilized as an intermediate for the development of indole-based compounds with potential pharmacological properties. Its contribution to medicinal chemistry and drug discovery is significant, as it aids in the creation of new pharmaceuticals and agrochemicals.
Used in Medicinal Chemistry:
6-Chloroindole-5-carbonitrile is employed in medicinal chemistry for its potential application in drug discovery. Its structural attributes and compatibility with functional groups make it an important tool in the design and synthesis of new therapeutic agents.
Used in Drug Development:
6-Chloroindole-5-carbonitrile is also used in drug development as a precursor to biologically active molecules. Its role in the synthesis of pharmaceuticals and agrochemicals highlights its importance in advancing the field of drug development and innovation.
Check Digit Verification of cas no
The CAS Registry Mumber 1423120-66-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,3,1,2 and 0 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1423120-66:
(9*1)+(8*4)+(7*2)+(6*3)+(5*1)+(4*2)+(3*0)+(2*6)+(1*6)=104
104 % 10 = 4
So 1423120-66-4 is a valid CAS Registry Number.
1423120-66-4Relevant articles and documents
SERINE/THREONINE PAK1 INHIBITORS
-
Page/Page column 161, (2013/03/26)
Compounds having the formula I wherein A, Z, R1a, R1b, R2, R3, R4, R5, R6, R7, R9, R10, Ra, Rb and n are as defined herein are inhibitors of PAK1. Also disclosed are compositions and methods for treating cancer and hyperproliferative disorders.